Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients

Abstract Background It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently report...

Full description

Bibliographic Details
Main Authors: Lujun Chen, Dawei Zhu, Jun Feng, You Zhou, Qi Wang, Huijing Feng, Junping Zhang, Jingting Jiang
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-019-0813-2
_version_ 1811288384269713408
author Lujun Chen
Dawei Zhu
Jun Feng
You Zhou
Qi Wang
Huijing Feng
Junping Zhang
Jingting Jiang
author_facet Lujun Chen
Dawei Zhu
Jun Feng
You Zhou
Qi Wang
Huijing Feng
Junping Zhang
Jingting Jiang
author_sort Lujun Chen
collection DOAJ
description Abstract Background It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported member of B7 family, is uniquely expressed in humans but not in mice, and it plays an important role in the functional inhibition of CD4 and CD8 T cells. Herein, we aimed to study the clinical implications of HHLA2 expression in human ccRCC and its potential regulatory role in the biological functions of the cancer cells. Methods In the present study, we examined HHLA2 expression in human ccRCC tissues and analyzed the clinical implications as well as prognostic value. The intervention of HHLA2 in human ccRCC cell lines ACHN and 786-O was performed and its effect on the cellular function of the cells was also analyzed. We also identified the differentially expressed genes upon HHLA2 knockdown in ccRCC cell lines by using gene microarray analysis. Results We found that higher HHLA2 mRNA expression level in human ccRCC tissues compared with that in adjacent normal tissues based on TCGA data, and the HHLA2 expression at mRNA level was positively and significantly correlated with PD-L1, PD-L2, B7-H6, but negatively and significantly correlated with B7-H3. Moreover, our immunohistochemistry study showed that the staining intensity of HHLA2 in human ccRCC tissues was significantly higher than that in the adjacent normal tissues, and the overall survival rate of ccRCC patients with higher HHLA2 expression was significantly poorer than that of the patients with lower HHLA2 expression. Higher expression of HHLA2 in ccRCC tissues was positively and significantly associated with larger tumor size and advanced TNM stage. The COX model revealed that the parameters including patient’s age, TNM stage and HHLA2 expression level could be used as the independent risk factors respectively for the prognostic prediction of the patients. Our cellular study showed that upon knockdown of HHLA2 expression in human ccRCC cell lines, the cell viability, the migration and the invasion ability were significantly inhibited, while the cell cycle arrest at G1 phase was induced and the expressions of Cyclin D1, c-Myc and Cyclin E1 were decreased. In addition, according to the microarray data, the expressions of epithelia-to-mesenchymal transition markers, such as E-cadherin, N-cadherin and Vimentin, were significantly changed after knockdown of HHLA2 expression. Conclusions Our findings indicated that HHLA2 was involved in the progression of human ccRCC and could be used as an important prognostic predictor for this malignancy.
first_indexed 2024-04-13T03:35:11Z
format Article
id doaj.art-c7c7005921314db680fe6e86edab185a
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-13T03:35:11Z
publishDate 2019-04-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-c7c7005921314db680fe6e86edab185a2022-12-22T03:04:20ZengBMCCancer Cell International1475-28672019-04-0119111210.1186/s12935-019-0813-2Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patientsLujun Chen0Dawei Zhu1Jun Feng2You Zhou3Qi Wang4Huijing Feng5Junping Zhang6Jingting Jiang7Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow UniversityDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow UniversityDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow UniversityDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow UniversityDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow UniversityDepartment of Oncology, Shanxi Academy of Medical Sciences, Shanxi Dayi HospitalDepartment of Oncology, Shanxi Academy of Medical Sciences, Shanxi Dayi HospitalDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow UniversityAbstract Background It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported member of B7 family, is uniquely expressed in humans but not in mice, and it plays an important role in the functional inhibition of CD4 and CD8 T cells. Herein, we aimed to study the clinical implications of HHLA2 expression in human ccRCC and its potential regulatory role in the biological functions of the cancer cells. Methods In the present study, we examined HHLA2 expression in human ccRCC tissues and analyzed the clinical implications as well as prognostic value. The intervention of HHLA2 in human ccRCC cell lines ACHN and 786-O was performed and its effect on the cellular function of the cells was also analyzed. We also identified the differentially expressed genes upon HHLA2 knockdown in ccRCC cell lines by using gene microarray analysis. Results We found that higher HHLA2 mRNA expression level in human ccRCC tissues compared with that in adjacent normal tissues based on TCGA data, and the HHLA2 expression at mRNA level was positively and significantly correlated with PD-L1, PD-L2, B7-H6, but negatively and significantly correlated with B7-H3. Moreover, our immunohistochemistry study showed that the staining intensity of HHLA2 in human ccRCC tissues was significantly higher than that in the adjacent normal tissues, and the overall survival rate of ccRCC patients with higher HHLA2 expression was significantly poorer than that of the patients with lower HHLA2 expression. Higher expression of HHLA2 in ccRCC tissues was positively and significantly associated with larger tumor size and advanced TNM stage. The COX model revealed that the parameters including patient’s age, TNM stage and HHLA2 expression level could be used as the independent risk factors respectively for the prognostic prediction of the patients. Our cellular study showed that upon knockdown of HHLA2 expression in human ccRCC cell lines, the cell viability, the migration and the invasion ability were significantly inhibited, while the cell cycle arrest at G1 phase was induced and the expressions of Cyclin D1, c-Myc and Cyclin E1 were decreased. In addition, according to the microarray data, the expressions of epithelia-to-mesenchymal transition markers, such as E-cadherin, N-cadherin and Vimentin, were significantly changed after knockdown of HHLA2 expression. Conclusions Our findings indicated that HHLA2 was involved in the progression of human ccRCC and could be used as an important prognostic predictor for this malignancy.http://link.springer.com/article/10.1186/s12935-019-0813-2HHLA2Clear cell renal cell carcinomaPrognosisEpithelial-to-mesenchymal transition
spellingShingle Lujun Chen
Dawei Zhu
Jun Feng
You Zhou
Qi Wang
Huijing Feng
Junping Zhang
Jingting Jiang
Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
Cancer Cell International
HHLA2
Clear cell renal cell carcinoma
Prognosis
Epithelial-to-mesenchymal transition
title Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
title_full Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
title_fullStr Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
title_full_unstemmed Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
title_short Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
title_sort overexpression of hhla2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
topic HHLA2
Clear cell renal cell carcinoma
Prognosis
Epithelial-to-mesenchymal transition
url http://link.springer.com/article/10.1186/s12935-019-0813-2
work_keys_str_mv AT lujunchen overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT daweizhu overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT junfeng overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT youzhou overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT qiwang overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT huijingfeng overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT junpingzhang overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients
AT jingtingjiang overexpressionofhhla2inhumanclearcellrenalcellcarcinomaissignificantlyassociatedwithpoorsurvivalofthepatients